nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—Electrocardiogram ST segment depression—Doxorubicin—muscle cancer	0.0408	0.0408	CcSEcCtD
Conivaptan—Sepsis—Dactinomycin—muscle cancer	0.0214	0.0214	CcSEcCtD
Conivaptan—Phlebitis—Dactinomycin—muscle cancer	0.0208	0.0208	CcSEcCtD
Conivaptan—Urine output increased—Vincristine—muscle cancer	0.0199	0.0199	CcSEcCtD
Conivaptan—Polyuria—Vincristine—muscle cancer	0.0182	0.0182	CcSEcCtD
Conivaptan—Candida infection—Etoposide—muscle cancer	0.0171	0.0171	CcSEcCtD
Conivaptan—Hyponatraemia—Vincristine—muscle cancer	0.0161	0.0161	CcSEcCtD
Conivaptan—Sepsis—Etoposide—muscle cancer	0.0155	0.0155	CcSEcCtD
Conivaptan—Phlebitis—Etoposide—muscle cancer	0.0151	0.0151	CcSEcCtD
Conivaptan—Dehydration—Vincristine—muscle cancer	0.0149	0.0149	CcSEcCtD
Conivaptan—Hypomagnesaemia—Doxorubicin—muscle cancer	0.0146	0.0146	CcSEcCtD
Conivaptan—Oral candidiasis—Doxorubicin—muscle cancer	0.0146	0.0146	CcSEcCtD
Conivaptan—Pneumonia—Dactinomycin—muscle cancer	0.0139	0.0139	CcSEcCtD
Conivaptan—Cardiac failure—Etoposide—muscle cancer	0.0133	0.0133	CcSEcCtD
Conivaptan—Pneumonia—Vincristine—muscle cancer	0.0124	0.0124	CcSEcCtD
Conivaptan—Urinary tract disorder—Vincristine—muscle cancer	0.0109	0.0109	CcSEcCtD
Conivaptan—Urethral disorder—Vincristine—muscle cancer	0.0109	0.0109	CcSEcCtD
Conivaptan—Erythema—Dactinomycin—muscle cancer	0.0108	0.0108	CcSEcCtD
Conivaptan—Cardiac disorder—Vincristine—muscle cancer	0.0103	0.0103	CcSEcCtD
Conivaptan—Pneumonia—Etoposide—muscle cancer	0.0101	0.0101	CcSEcCtD
Conivaptan—Angiopathy—Vincristine—muscle cancer	0.01	0.01	CcSEcCtD
Conivaptan—Infestation NOS—Etoposide—muscle cancer	0.00999	0.00999	CcSEcCtD
Conivaptan—Infestation—Etoposide—muscle cancer	0.00999	0.00999	CcSEcCtD
Conivaptan—Mediastinal disorder—Vincristine—muscle cancer	0.00998	0.00998	CcSEcCtD
Conivaptan—Anaemia—Dactinomycin—muscle cancer	0.00997	0.00997	CcSEcCtD
Conivaptan—Mental disorder—Vincristine—muscle cancer	0.0097	0.0097	CcSEcCtD
Conivaptan—Urine output increased—Methotrexate—muscle cancer	0.00968	0.00968	CcSEcCtD
Conivaptan—Sepsis—Methotrexate—muscle cancer	0.00929	0.00929	CcSEcCtD
Conivaptan—Anaemia—Vincristine—muscle cancer	0.00891	0.00891	CcSEcCtD
Conivaptan—Urinary tract disorder—Etoposide—muscle cancer	0.00886	0.00886	CcSEcCtD
Conivaptan—Polyuria—Methotrexate—muscle cancer	0.00885	0.00885	CcSEcCtD
Conivaptan—Candida infection—Doxorubicin—muscle cancer	0.00885	0.00885	CcSEcCtD
Conivaptan—Urethral disorder—Etoposide—muscle cancer	0.00879	0.00879	CcSEcCtD
Conivaptan—Infection—Dactinomycin—muscle cancer	0.00875	0.00875	CcSEcCtD
Conivaptan—Cardiac disorder—Etoposide—muscle cancer	0.00833	0.00833	CcSEcCtD
Conivaptan—Hypertension—Vincristine—muscle cancer	0.00832	0.00832	CcSEcCtD
Conivaptan—Angiopathy—Etoposide—muscle cancer	0.00814	0.00814	CcSEcCtD
Conivaptan—Mediastinal disorder—Etoposide—muscle cancer	0.00809	0.00809	CcSEcCtD
Conivaptan—Sepsis—Doxorubicin—muscle cancer	0.00804	0.00804	CcSEcCtD
Conivaptan—Infection—Vincristine—muscle cancer	0.00782	0.00782	CcSEcCtD
Conivaptan—Phlebitis—Doxorubicin—muscle cancer	0.00781	0.00781	CcSEcCtD
Conivaptan—Nervous system disorder—Vincristine—muscle cancer	0.00772	0.00772	CcSEcCtD
Conivaptan—Pain—Dactinomycin—muscle cancer	0.00753	0.00753	CcSEcCtD
Conivaptan—Hypotension—Vincristine—muscle cancer	0.00735	0.00735	CcSEcCtD
Conivaptan—Feeling abnormal—Dactinomycin—muscle cancer	0.00726	0.00726	CcSEcCtD
Conivaptan—Anaemia—Etoposide—muscle cancer	0.00722	0.00722	CcSEcCtD
Conivaptan—Insomnia—Vincristine—muscle cancer	0.00712	0.00712	CcSEcCtD
Conivaptan—Body temperature increased—Dactinomycin—muscle cancer	0.00696	0.00696	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—muscle cancer	0.00689	0.00689	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—muscle cancer	0.00689	0.00689	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Vincristine—muscle cancer	0.00679	0.00679	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—muscle cancer	0.00675	0.00675	CcSEcCtD
Conivaptan—Hypertension—Etoposide—muscle cancer	0.00674	0.00674	CcSEcCtD
Conivaptan—Constipation—Vincristine—muscle cancer	0.00673	0.00673	CcSEcCtD
Conivaptan—Pain—Vincristine—muscle cancer	0.00673	0.00673	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0066	0.0066	CcSEcCtD
Conivaptan—Confusional state—Etoposide—muscle cancer	0.00643	0.00643	CcSEcCtD
Conivaptan—Infection—Etoposide—muscle cancer	0.00633	0.00633	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—muscle cancer	0.00626	0.00626	CcSEcCtD
Conivaptan—Body temperature increased—Vincristine—muscle cancer	0.00622	0.00622	CcSEcCtD
Conivaptan—Skin disorder—Etoposide—muscle cancer	0.00619	0.00619	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00614	0.00614	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—muscle cancer	0.00612	0.00612	CcSEcCtD
Conivaptan—Diarrhoea—Dactinomycin—muscle cancer	0.00603	0.00603	CcSEcCtD
Conivaptan—Pneumonia—Methotrexate—muscle cancer	0.00602	0.00602	CcSEcCtD
Conivaptan—Infestation NOS—Methotrexate—muscle cancer	0.00599	0.00599	CcSEcCtD
Conivaptan—Infestation—Methotrexate—muscle cancer	0.00599	0.00599	CcSEcCtD
Conivaptan—Hypotension—Etoposide—muscle cancer	0.00596	0.00596	CcSEcCtD
Conivaptan—Haematuria—Methotrexate—muscle cancer	0.00571	0.00571	CcSEcCtD
Conivaptan—Vomiting—Dactinomycin—muscle cancer	0.0056	0.0056	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Etoposide—muscle cancer	0.0055	0.0055	CcSEcCtD
Conivaptan—Pain—Etoposide—muscle cancer	0.00545	0.00545	CcSEcCtD
Conivaptan—Constipation—Etoposide—muscle cancer	0.00545	0.00545	CcSEcCtD
Conivaptan—Diarrhoea—Vincristine—muscle cancer	0.00538	0.00538	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—muscle cancer	0.00537	0.00537	CcSEcCtD
Conivaptan—Urinary tract disorder—Methotrexate—muscle cancer	0.00531	0.00531	CcSEcCtD
Conivaptan—Urethral disorder—Methotrexate—muscle cancer	0.00527	0.00527	CcSEcCtD
Conivaptan—Feeling abnormal—Etoposide—muscle cancer	0.00525	0.00525	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—muscle cancer	0.00524	0.00524	CcSEcCtD
Conivaptan—Nausea—Dactinomycin—muscle cancer	0.00523	0.00523	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—muscle cancer	0.00521	0.00521	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—muscle cancer	0.00518	0.00518	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—muscle cancer	0.00518	0.00518	CcSEcCtD
Conivaptan—Body temperature increased—Etoposide—muscle cancer	0.00504	0.00504	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—muscle cancer	0.00504	0.00504	CcSEcCtD
Conivaptan—Vomiting—Vincristine—muscle cancer	0.005	0.005	CcSEcCtD
Conivaptan—Cardiac disorder—Methotrexate—muscle cancer	0.00499	0.00499	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—muscle cancer	0.00494	0.00494	CcSEcCtD
Conivaptan—Headache—Vincristine—muscle cancer	0.00493	0.00493	CcSEcCtD
Conivaptan—Angiopathy—Methotrexate—muscle cancer	0.00488	0.00488	CcSEcCtD
Conivaptan—Mediastinal disorder—Methotrexate—muscle cancer	0.00484	0.00484	CcSEcCtD
Conivaptan—Mental disorder—Methotrexate—muscle cancer	0.00471	0.00471	CcSEcCtD
Conivaptan—Malnutrition—Methotrexate—muscle cancer	0.00468	0.00468	CcSEcCtD
Conivaptan—Erythema—Methotrexate—muscle cancer	0.00468	0.00468	CcSEcCtD
Conivaptan—Nausea—Vincristine—muscle cancer	0.00467	0.00467	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—muscle cancer	0.0046	0.0046	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—muscle cancer	0.00458	0.00458	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—muscle cancer	0.00456	0.00456	CcSEcCtD
Conivaptan—Pruritus—Etoposide—muscle cancer	0.00451	0.00451	CcSEcCtD
Conivaptan—Diarrhoea—Etoposide—muscle cancer	0.00436	0.00436	CcSEcCtD
Conivaptan—Anaemia—Methotrexate—muscle cancer	0.00432	0.00432	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—muscle cancer	0.00432	0.00432	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—muscle cancer	0.00422	0.00422	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—muscle cancer	0.00419	0.00419	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—muscle cancer	0.00408	0.00408	CcSEcCtD
Conivaptan—Vomiting—Etoposide—muscle cancer	0.00405	0.00405	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—muscle cancer	0.00405	0.00405	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—muscle cancer	0.00405	0.00405	CcSEcCtD
Conivaptan—Headache—Etoposide—muscle cancer	0.00399	0.00399	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00396	0.00396	CcSEcCtD
Conivaptan—Confusional state—Methotrexate—muscle cancer	0.00385	0.00385	CcSEcCtD
Conivaptan—Infection—Methotrexate—muscle cancer	0.00379	0.00379	CcSEcCtD
Conivaptan—Nausea—Etoposide—muscle cancer	0.00379	0.00379	CcSEcCtD
Conivaptan—Nervous system disorder—Methotrexate—muscle cancer	0.00374	0.00374	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—muscle cancer	0.00374	0.00374	CcSEcCtD
Conivaptan—Skin disorder—Methotrexate—muscle cancer	0.00371	0.00371	CcSEcCtD
Conivaptan—Hypotension—Methotrexate—muscle cancer	0.00357	0.00357	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—muscle cancer	0.0035	0.0035	CcSEcCtD
Conivaptan—Insomnia—Methotrexate—muscle cancer	0.00345	0.00345	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00342	0.00342	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—muscle cancer	0.00337	0.00337	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—muscle cancer	0.00333	0.00333	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methotrexate—muscle cancer	0.0033	0.0033	CcSEcCtD
Conivaptan—Infection—Doxorubicin—muscle cancer	0.00328	0.00328	CcSEcCtD
Conivaptan—Pain—Methotrexate—muscle cancer	0.00326	0.00326	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—muscle cancer	0.00324	0.00324	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—muscle cancer	0.00321	0.00321	CcSEcCtD
Conivaptan—Feeling abnormal—Methotrexate—muscle cancer	0.00315	0.00315	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—muscle cancer	0.00309	0.00309	CcSEcCtD
Conivaptan—Body temperature increased—Methotrexate—muscle cancer	0.00302	0.00302	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—muscle cancer	0.00299	0.00299	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00285	0.00285	CcSEcCtD
Conivaptan—Pain—Doxorubicin—muscle cancer	0.00283	0.00283	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—muscle cancer	0.00283	0.00283	CcSEcCtD
Conivaptan—Feeling abnormal—Doxorubicin—muscle cancer	0.00272	0.00272	CcSEcCtD
Conivaptan—Pruritus—Methotrexate—muscle cancer	0.0027	0.0027	CcSEcCtD
Conivaptan—Body temperature increased—Doxorubicin—muscle cancer	0.00261	0.00261	CcSEcCtD
Conivaptan—Diarrhoea—Methotrexate—muscle cancer	0.00261	0.00261	CcSEcCtD
Conivaptan—Vomiting—Methotrexate—muscle cancer	0.00243	0.00243	CcSEcCtD
Conivaptan—Headache—Methotrexate—muscle cancer	0.00239	0.00239	CcSEcCtD
Conivaptan—Pruritus—Doxorubicin—muscle cancer	0.00234	0.00234	CcSEcCtD
Conivaptan—Nausea—Methotrexate—muscle cancer	0.00227	0.00227	CcSEcCtD
Conivaptan—Diarrhoea—Doxorubicin—muscle cancer	0.00226	0.00226	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Conivaptan—Headache—Doxorubicin—muscle cancer	0.00207	0.00207	CcSEcCtD
Conivaptan—Nausea—Doxorubicin—muscle cancer	0.00196	0.00196	CcSEcCtD
